NCT02203305View on ClinicalTrials.gov

Cochlear Implantation in Cases of Single-Sided Deafness

NACompletedINTERVENTIONAL
Enrollment

43

Participants

Timeline

Start Date

October 31, 2014

Primary Completion Date

September 16, 2021

Study Completion Date

September 16, 2021

Conditions
Unilateral Moderate to Profound Hearing LossAsymmetric Hearing LossSingle-Sided Deafness (SSD)
Interventions
DEVICE

Cochlear Implant

cochlear implantation used a treatment for single-sided deafness and/or asymmetric hearing loss

OTHER

Control Group

Subjects in the control group will have had listening experience with a bone-conduction device, which is an approved treatment for SSD.

Trial Locations (1)

27517

University of North Carolina at Chapel Hill, Chapel Hill

Sponsors

Collaborators (1)

Med-El Corporation
All Listed Sponsors
collaborator

Med-El Corporation

INDUSTRY

lead

University of North Carolina, Chapel Hill

OTHER

NCT02203305 - Cochlear Implantation in Cases of Single-Sided Deafness | Biotech Hunter | Biotech Hunter